© 1996 American Heart Association, Inc.
Articles |
Enhancer Stimulation Unmasks Latent Gene Transfer After Adenovirus-Mediated Gene Delivery Into Human Vascular Smooth Muscle Cells
the Department of Medicine (G.J.C., P.L.W.) and the Division of Virology, Department of Pathology (H.B., S.E.), University of Cambridge (UK), Addenbrooke's Hospital.
Correspondence to Dr G.J. Clesham, Department of Medicine (Level 5), Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ UK. E-mail gjc@mole.bio.cam.ac.uk.
Recombinant adenoviral vectors are being used increasingly for gene transfer studies in mammalian cells and gene therapy protocols in humans. High adenoviral titers are often required for successful transduction of vascular smooth muscle cells (VSMCs), defined as uptake and detectable expression of the foreign gene, but the relative contributions of efficiency of viral uptake and control of transcription are poorly understood. To explore the extent to which a lack of detectable gene expression may be due to inefficient transcription of a successfully transferred gene, we have used a replication-deficient adenovirus expressing ß-galactosidase (RAd35ß-Gal), under the control of the human cytomegalovirus major immediate-early promoter (CMV-IEP), which contains cAMP and nuclear factor-
B response elements, to investigate constitutive and inducible gene expression after gene transfer into human VSMCs. Histochemical staining with 5-bromo-4-chloro-3-indolyl ß-D-galactopyranoside (X-gal), a quantitative spectrophotometric assay, SDS-PAGE, Western blotting, and Northern analysis were used to evaluate ß-galactosidase expression in infected cells. After infection with RAd35ß-Gal at 30, 100, and 1000 plaque-forming units per cell (pfu/cell), expression of ß-galactosidase was augmented up to 17-, 19-, and 23-fold, respectively, in human VSMCs treated with forskolin and phorbol ester compared with unstimulated cells. After infection, the proportion of detectably transduced cells was increased by enhancer stimulation from 58% to 100% at 100 pfu/cell and from 9% to 62% at 10 pfu/cell, indicating quiescent viral DNA in unstimulated cells. At high adenoviral titers (1000 pfu/cell), the recombinant gene became the most abundant protein in cell extracts. These findings demonstrate that in human VSMCs, limited constitutive expression from the CMV-IEP, rather than failure of translocation of adenoviral DNA, may be responsible for the apparent failure of transduction at a low multiplicity of infection.
Key Words: gene transfer • adenovirus • gene expression • enhancer stimulation
This article has been cited by other articles:
 |
|
 |
|
  R. A. Katz, E. Jack-Scott, A. Narezkina, I. Palagin, P. Boimel, J. Kulkosky, E. Nicolas, J. G. Greger, and A. M. Skalka High-Frequency Epigenetic Repression and Silencing of Retroviruses Can Be Antagonized by Histone Deacetylase Inhibitors and Transcriptional Activators, but Uniform Reactivation in Cell Clones Is Restricted by Additional Mechanisms J. Virol., March 15, 2007; 81(6): 2592 - 2604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wen, S. Graf, P. G. Massey, and D. A. Dichek Improved Vascular Gene Transfer With a Helper-Dependent Adenoviral Vector Circulation, September 14, 2004; 110(11): 1484 - 1491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C.M Siow, C. M Mallawaarachchi, and P. L Weissberg Migration of adventitial myofibroblasts following vascular balloon injury: insights from in vivo gene transfer to rat carotid arteries Cardiovasc Res, July 1, 2003; 59(1): 212 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Somers, J. A. DeLoia, and A. J. Zeleznik Adenovirus-Directed Expression of a Nonphosphorylatable Mutant of CREB (cAMP Response Element-Binding Protein) Adversely Affects the Survival, but Not the Differentiation, of Rat Granulosa Cells Mol. Endocrinol., August 1, 1999; 13(8): 1364 - 1372. [Abstract] [Full Text]
|
|
|
|
 |
|
 P A KINGSTON and A M HEAGERTY Gene therapy made difficult Heart, July 1, 1999; 82(1): 115 - 115. [Full Text]
|
|
|
|
|
|
G J CLESHAM Gene therapy made difficult Heart, October 1, 1998; 80(4): 313 - 314. [Full Text]
|
|
|
|
 |
|
 S. D. Christenson, K. D. Lake, H. Ooboshi, F. M. Faraci, B. L. Davidson, D. D. Heistad, and S. P. Finklestein Adenovirus-Mediated Gene Transfer In Vivo to Cerebral Blood Vessels and Perivascular Tissue in Mice • Editorial Comment Stroke, July 1, 1998; 29(7): 1411 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sata, H. Perlman, D. A. Muruve, M. Silver, M. Ikebe, T. A. Libermann, P. Oettgen, and K. Walsh Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response PNAS, February 3, 1998; 95(3): 1213 - 1217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Loser, G. S. Jennings, M. Strauss, and V. Sandig Reactivation of the Previously Silenced Cytomegalovirus Major Immediate-Early Promoter in the Mouse Liver: Involvement of NFkappa B J. Virol., January 1, 1998; 72(1): 180 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Maillard, E. Van Belle, R. C Smith, A. Le Roux, P. Denefle, G. Steg, J. J Barry, D. Branellec, J. M Isner, and K. Walsh Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty Cardiovasc Res, September 1, 1997; 35(3): 536 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R C Smith, D Branellec, D H Gorski, K Guo, H Perlman, J F Dedieu, C Pastore, A Mahfoudi, P Denefle, J M Isner, et al. p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes & Dev., July 1, 1997; 11(13): 1674 - 1689. [Abstract] [PDF]
|
|